Clinical Trial Update: LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating survodutide for metabolic dysfunction-associated steatohepatitis (NASH) with cirrhosis is currently recruiting. The study is s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Metabolic Dysfunction-associated Steatohepatitis

Drugs mentioned

• Survodutide (BI456906)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Metabolic Dysfunction Associated Steatohepatitis | Phase 3 | Status: RECRUITING